These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34447415)

  • 21. Renal involvement in PMM2-CDG, a mini-review.
    Altassan R; Witters P; Saifudeen Z; Quelhas D; Jaeken J; Levtchenko E; Cassiman D; Morava E
    Mol Genet Metab; 2018 Mar; 123(3):292-296. PubMed ID: 29229467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage.
    Stefanits H; Konstantopoulou V; Kuess M; Milenkovic I; Matula C
    J Neurosurg Pediatr; 2014 Nov; 14(5):546-9. PubMed ID: 25192236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
    Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
    Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2.
    Chan B; Clasquin M; Smolen GA; Histen G; Powe J; Chen Y; Lin Z; Lu C; Liu Y; Cang Y; Yan Z; Xia Y; Thompson R; Singleton C; Dorsch M; Silverman L; Su SM; Freeze HH; Jin S
    Hum Mol Genet; 2016 Jun; 25(11):2182-2193. PubMed ID: 27053713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
    Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
    Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD).
    Kaler SG; Ferreira CR; Yam LS
    Mol Genet Metab Rep; 2020 Sep; 24():100602. PubMed ID: 32528851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy.
    Izquierdo-Serra M; Martínez-Monseny AF; López L; Carrillo-García J; Edo A; Ortigoza-Escobar JD; García Ó; Cancho-Candela R; Carrasco-Marina ML; Gutiérrez-Solana LG; Cuadras D; Muchart J; Montero R; Artuch R; Pérez-Cerdá C; Pérez B; Pérez-Dueñas B; Macaya A; Fernández-Fernández JM; Serrano M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29470411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Population-Based Study on Congenital Disorders of Protein N- and Combined with O-Glycosylation Experience in Clinical and Genetic Diagnosis.
    Pérez-Cerdá C; Girós ML; Serrano M; Ecay MJ; Gort L; Pérez Dueñas B; Medrano C; García-Alix A; Artuch R; Briones P; Pérez B
    J Pediatr; 2017 Apr; 183():170-177.e1. PubMed ID: 28139241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.
    Lao JP; DiPrimio N; Prangley M; Sam FS; Mast JD; Perlstein EO
    G3 (Bethesda); 2019 Feb; 9(2):413-423. PubMed ID: 30530630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up.
    Bogdańska A; Lipiński P; Szymańska-Rożek P; Jezela-Stanek A; Rokicki D; Socha P; Tylki-Szymańska A
    Orphanet J Rare Dis; 2021 Jan; 16(1):17. PubMed ID: 33407696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutritional Therapies in Congenital Disorders of Glycosylation (CDG).
    Witters P; Cassiman D; Morava E
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29112118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital Disorders of Glycosylation in Portugal-Two Decades of Experience.
    Quelhas D; Martins E; Azevedo L; Bandeira A; Diogo L; Garcia P; Sequeira S; Ferreira AC; Teles EL; Rodrigues E; Fortuna AM; Mendonça C; Fernandes HC; Medeira A; Gaspar A; Janeiro P; Oliveira A; Laranjeira F; Ribeiro I; Souche E; Race V; Keldermans L; Matthijs G; Jaeken J
    J Pediatr; 2021 Apr; 231():148-156. PubMed ID: 33340551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital disorders of glycosylation with emphasis on cerebellar involvement.
    Barone R; Fiumara A; Jaeken J
    Semin Neurol; 2014 Jul; 34(3):357-66. PubMed ID: 25192513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls.
    Asteggiano CG; Papazoglu M; Bistué Millón MB; Peralta MF; Azar NB; Spécola NS; Guelbert N; Suldrup NS; Pereyra M; Dodelson de Kremer R
    Pediatr Res; 2018 Dec; 84(6):837-841. PubMed ID: 30397276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing.
    Timal S; Hoischen A; Lehle L; Adamowicz M; Huijben K; Sykut-Cegielska J; Paprocka J; Jamroz E; van Spronsen FJ; Körner C; Gilissen C; Rodenburg RJ; Eidhof I; Van den Heuvel L; Thiel C; Wevers RA; Morava E; Veltman J; Lefeber DJ
    Hum Mol Genet; 2012 Oct; 21(19):4151-61. PubMed ID: 22492991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG.
    Bengtson P; Ng BG; Jaeken J; Matthijs G; Freeze HH; Eklund EA
    J Inherit Metab Dis; 2016 Jan; 39(1):107-14. PubMed ID: 26335155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wrinkled skin and fat pads in patients with ALG8-CDG: revisiting skin manifestations in congenital disorders of glycosylation.
    Kouwenberg D; Gardeitchik T; Mohamed M; Lefeber DJ; Morava E
    Pediatr Dermatol; 2014; 31(1):e1-5. PubMed ID: 24555185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
    Jones MA; Rhodenizer D; da Silva C; Huff IJ; Keong L; Bean LJ; Coffee B; Collins C; Tanner AK; He M; Hegde MR
    Mol Genet Metab; 2013; 110(1-2):78-85. PubMed ID: 23806237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification through exome sequencing of the first PMM2-CDG individual of Mexican mestizo origin.
    González-Domínguez CA; Raya-Trigueros A; Manrique-Hernández S; González Jaimes A; Salinas-Marín R; Molina-Garay C; Carrillo-Sánchez K; Flores-Lagunes LL; Jiménez-Olivares M; Dehesa-Caballero C; Alaez-Versón C; Martínez-Duncker I
    Mol Genet Metab Rep; 2020 Dec; 25():100637. PubMed ID: 32874916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital disorders of glycosylation (CDG): Quo vadis?
    Péanne R; de Lonlay P; Foulquier F; Kornak U; Lefeber DJ; Morava E; Pérez B; Seta N; Thiel C; Van Schaftingen E; Matthijs G; Jaeken J
    Eur J Med Genet; 2018 Nov; 61(11):643-663. PubMed ID: 29079546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.